• Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

  • Sep 24 2024
  • Length: 11 mins
  • Podcast

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

Listen for free

View show details

  • Summary

  • Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.


    (00:31)
    Would you share a little bit about yourself and your background?

    (01:11)
    Could you provide us with an overview of this particular peripheral neuropathy?

    (03:09)
    Can you share the background as to how your team learned about this condition and how you considered testing for it?

    (04:42)

    Would you explain what you saw when you performed the urine test on the first patient?

    (05:26)
    Were you able to test additional patients with this condition?

    (06:09)

    Could you expand on why this urine test is important?

    (07:20)
    How does a health care provider order urine testing for SORD deficiency?

    (07:59)
    How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu?

    (08:55)

    Could you summarize the benefits of ordering this SORD urine test at Mayo?
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available